Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000497334 | SCV000590081 | pathogenic | not provided | 2023-06-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33820833, 23623388) |
Genomic Medicine Lab, |
RCV001007949 | SCV001167663 | likely pathogenic | Wieacker-Wolff syndrome | 2019-03-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496910 | SCV002808706 | likely pathogenic | Wieacker-Wolff syndrome; Wieacker-Wolff syndrome, female-restricted | 2022-03-22 | criteria provided, single submitter | clinical testing | |
Victorian Clinical Genetics Services, |
RCV001007949 | SCV003921948 | pathogenic | Wieacker-Wolff syndrome | 2020-06-11 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as 5-Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0109 - This gene is known to be associated with X-linked recessive Wieacker-Wolff syndrome (OMIM). However, female pathogenic variant carriers can be affected or unaffected (PMID: 31206972). (N) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan (exon 5). (N) 0253 - Variant is hemizygous. (N) 0301 - Variant is absent from gnomAD. (P) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools and highly conserved with a major amino acid change. (P) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants. Variant is located in a cluster of pathogenic missense variants (Decipher). (P) 0704 - Comparable variant has low previous evidence for pathogenicity. The p.(Arg198Gln) comparable variant has been previously reported in three families with neurogenic arthrogryposis multiplex congenita, in both familial and de novo cases (PMIDs: 23623388; 31206972). (P) 0803 - Low previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic and likely pathogenic in ClinVar and LOVD. (P) 1007 - No published functional evidence has been identified for this variant. (N) 1203 - Variant shown to be de novo in proband (parental status confirmed). (P) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign |
Genome Diagnostics Laboratory, |
RCV000497334 | SCV001809609 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000497334 | SCV001954371 | likely pathogenic | not provided | no assertion criteria provided | clinical testing |